ClinicalTrials.gg
RecruitingNCT07715968TuBaUpdated Sep 11, 2026

The Turbine-based CO2 Insufflator Pediatric Feasibility Study

An interventional study of Turbine-based insufflator in Laparoscopy and Pneumoperitoneum, sponsored by Erasmus Medical Center. Recruiting at 1 site in Netherlands. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Erasmus Medical Center · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
Up to 18 Years
Sex
All
01

Study summary

A novel CO2 insufflator, the Turbine-based insufflator, has been developed to improve minimally invasive surgery. Turbine technology permits accurate pressure control resulting in an intra-abdominal volume that is dynamically adapted to ventilation. In addition, oscillometric measurements are performed to measure the abdominal compliance of the patient. This feasibility trial primarly aims to evaluate the technologic feasibility during pediatric laparoscopic surgery. Secondary outcomes are pressure stability, comparison of intra-abdominal pressure stability between the standard CO2 insufflator and the Turbine-based insufflator, and comparison of ventiliation pressures between these insufflators.

Read the detailed description

A new CO2 insufflator, the turbine-based insufflator (TBI), has been developed with an insufflation technique that enables highly accurate pressure control that is dynamically adapted to ventilation. It is hypothesized that this novel insufflation technique provides more stable abdominal pressures than conventional insufflators and reduces the need for high ventilation pressures. The pediatric population can benefit greatly from this new insufflation technique, as small changes in pressure settings and stabilization of the surgical field already have a relatively large impact.

02

Conditions studied

  • Laparoscopy
  • Pneumoperitoneum

Browse trials for

Keywords

  • Pneumoperitoneum
  • Device development
  • Insufflator
  • Laparoscopy
03

In context

Pneumoperitoneum

133 studies on the registry are indexed under Pneumoperitoneum; 28 are open to participants now.

This study's planned enrollment of 12 is below the median of 76 across 77 interventional studies indexed under Pneumoperitoneum.

Browse Pneumoperitoneum studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 479 studies on the registry; 182 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Weight ≥ 10 kilograms;
  • Laparoscopic procedure;
  • Intraperitoneal procedure;
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Inability to use the study-specific trocar during the procedure (surgeon's assessment);
  • The expected time for abdominal insufflation is less than 20 minutes;
  • Conversion to open surgery within 10 minutes after study measurements;
  • Pregnancy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Pediatric laparoscopy

    Pediatric population, planned for intraperitoneal laparoscopic surgery.

    Device: Turbine-based insufflator

Interventions

  • DeviceTurbine-based insufflator

    Use of the Tubine-based insufflator during surgical procedure.

06

What researchers measure

Primary outcomes

  1. The number of adverse device events as assessed by observations during the procedure (qualitative measurements)

    Observations of researcher and surgeon (number of adverse device events)

    Time frame: During surgery

Secondary outcomes

  1. Assessment of intra-abdominal pressure stability, assessed by the median and interquartile range of the actual measured pressure

    Recording the intra-abdominal pressure with a pressure line during the surgical procedure. Assessment of the difference between the actual measured pressure and the target pressure. Stability is defined as the median pressure with the interquartile range.

    Time frame: During surgery

  2. Registration of events that impair intra-abdominal pressure stability (observationa, qualitative)

    Time frame: During surgery

  3. Comparison of intra-abdominal pressure stability and ventilation pressures between conventional insufflation and turbine-based insufflation by comparing median, minimum, and maximum pressures.

    Between turbine-based insufflation and conventional insufflation.

    Time frame: During surgery

  4. Abdominal compliance by performing endoscopic oscillometry in a pediatric population (using insufflation pressure and flow for calculating the abdominal compliance; quantitative measurements)

    Intra-abdominal pressure and intra-abdominal flow data recording during surgical procedure.

    Time frame: During surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.

Of 40 non-industry interventional studies with no phase under Pneumoperitoneum, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 14. This study's planned 9 months is above that.

Counting every sponsor, half of 40 studies reached it within 8 months; a quarter within 4 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 27, 2026
First posted
Jul 21, 2026
StartActual
Feb 10, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07715968
Collaborators
Politecnico di Milano University, Health∼Holland, Topsector Life Sciences & Health, Spatium Medical B.V.
Responsible party
Ass. Prof. J (John) Vlot MD, PhD, FEBPS (Consultant pediatric surgeon, Erasmus Medical Center) — Principal investigator
First posted
Jul 21, 2026
Start date
Feb 10, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 11, 2026

Study contacts

A.I. Jong
Contact
a.i.dejong@erasmusmc.nl
+31107037641
J. Vlot
Contact
+31107039568
J. Vlot
principal investigator · Erasmus Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion